Influenza Vaccination and Reduction in Hospitalizations for Cardiac Disease and Stroke among the Elderly
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Upper respiratory tract illnesses have been associated with an increased risk of ischemic heart disease and stroke. During two influenza seasons, we assessed the influence of vaccination against influenza on the risk of hospitalization for heart disease and stroke, hospitalization for pneumonia and influenza, and death from all causes. METHODS: Cohorts of community-dwelling members of three large managed-care organizations who were at least 65 years old were studied during the 1998-1999 and 1999-2000 influenza seasons. Administrative and clinical data were used to evaluate outcomes, with multivariable logistic regression to control for base-line demographic and health characteristics of the subjects. RESULTS: There were 140,055 subjects in the 1998-1999 cohort and 146,328 in the 1999-2000 cohort, of which 55.5 percent and 59.7 percent, respectively, were immunized. At base line, vaccinated subjects were on average sicker, having higher rates of most coexisting conditions, outpatient care, and prior hospitalization for pneumonia than unvaccinated subjects. Unvaccinated subjects, however, were more likely to have been given a prior diagnosis of dementia or stroke. Vaccination against influenza was associated with a reduction in the risk of hospitalization for cardiac disease (reduction of 19 percent during both seasons [P<0.001]), cerebrovascular disease (reduction of 16 percent during the 1998-1999 season [P<0.018] and 23 percent during the 1999-2000 season [P<0.001]), and pneumonia or influenza (reduction of 32 percent during the 1998-1999 season [P<0.001] and 29 percent during the 1999-2000 season [P<0.001]) and a reduction in the risk of death from all causes (reduction of 48 percent during the 1998-1999 season [P<0.001] and 50 percent during the 1999-2000 season [P<0.001]). In analyses according to age, the presence or absence of major medical conditions at base line, and study site, the findings were consistent across all subgroups. CONCLUSIONS: In the elderly, vaccination against influenza is associated with reductions in the risk of hospitalization for heart disease, cerebrovascular disease, and pneumonia or influenza as well as the risk of death from all causes during influenza seasons. These findings highlight the benefits of vaccination and support efforts to increase the rates of vaccination among the elderly.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Influenza vaccination as a population-wide prevention measure was associated with a very cost-effective reduction in clinical events.171”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [171]
Citations
Cites
Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States
Thompson, W. W., Shay, D. K., Weintraub, E., Brammer, L., Cox, N., Anderson, L. J., & Fukuda, K. (2003) · JAMA · doi:10.1001/jama.289.2.179 · Cited by 3,673
Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010.
Schrag, S. D., Gorwitz, R. J., Fultz-Butts, K., & Schuchat, A. (2002) · PubMed · Cited by 3,349
The number needed to treat: a clinically useful measure of treatment effect
Cook, R. J., & Sackett, D. L. (1995) · BMJ · doi:10.1136/bmj.310.6977.452 · Cited by 1,885
Holtzman, D. J., Powell‐Griner, E., Bolen, J. C., & Rhodes, L. (2000) · PubMed · Cited by 1,110
Nichol, K. L., Margolis, K. L., Wuorenma, J., & Von Sternberg, T. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409223311206 · Cited by 996
Self-citationInfection and Atherosclerosis: Emerging Mechanistic Paradigms
Epstein, S. E., Zhou, Y. F., & Zhu, J. (1999) · Circulation · doi:10.1161/01.cir.100.4.e20 · Cited by 511
Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens.
Nichol, K. L., Wuorenma, J., & von Sternberg, T. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.16.1769 · Cited by 484
Self-citationValidation of self-report of influenza and pneumococcal vaccination status in elderly outpatients
Mac Donald, R., Baken, L., Nelson, A., & Nichol, K. L. (1999) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(98)00159-7 · Cited by 410
Self-citationAcute respiratory-tract infections and risk of first-time acute myocardial infarction
Meier, C. R., Jick, S. S., Derby, L. E., Vasilakis, C., Jick, H., Meier, C., Jick, S., Derby, L., Vasilakis, C., & Jick, H. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11084-4 · Cited by 389
Vu, T., Farish, S., Jenkins, M., & Kelly, H. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00041-5 · Cited by 376
Research works printed but not linked: 7
- 2002, MMWR Morb Mortal Wkly Rep, 51, 1
- Nichol KL. Efficacy/clinical effectiveness of inactivated influenza virus vaccines in adults. In: Nicholson KG, Webster RG, Hay AJ, eds. Textbook of influenza. Oxford, England: Blackwell Science, 1998:358-72.
- Becher H, 2000, J Epidemiol Biostat, 5, 277
- 1999, MMWR Morb Mortal Wkly Rep, 48, 374
- 2000, MMWR Morb Mortal Wkly Rep, 49, 375
- 1997, MMWR Morb Mortal Wkly Rep, 46, 1
- Healthy People 2010: conference edition. Vol. 1. Washington, D.C.: Department of Health and Human Services, January 2000.
Cited by
Items 201–300 of 742
Scientific Justification of Cryonics Practice
Best, B. P. (2008) · Rejuvenation Research · doi:10.1089/rej.2008.0661 · Cited by 62
Vejpongsa, P., Kitkungvan, D., Madjid, M., Charitakis, K., Anderson, H. V., Arain, S. A., Balan, P., Smalling, R. W., & Dhoble, A. (2019) · The American Journal of Medicine · doi:10.1016/j.amjmed.2019.05.002 · Cited by 53
Racial similarities in response to standardized offer of influenza vaccination
Schwartz, K., Neale, A. V., Northrup, J., Monsur, J. C., Patel, D. A., Tobar, R., & WORTLEY, P. M. (2006) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2006.00401.x · Cited by 51
Philbin, V. J., & Levy, O. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351485 · Cited by 51
Comorbidity of patients with noncommunicable diseases in general practice. Eurasian guidelines
Drapkina, O. M., Васильевна, К. А., Калинина, А. М., Avdeev, S. N., Викторович, А. М., Алексеева, Л. И., Almazova, I. I., Andreenko, Е. Y., Antipushina, D. N., Balanova, Y. А., et al. (2024) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2024-3996 · Cited by 65
Siriwardena, A. N., Asghar, Z. B., & Coupland, C. A. C. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.01.029 · Cited by 55
(2008), G. D. T. D. L. E. P. E. D. Y. T. D. L. I. C. A. Y. C., & Desarrollada en colaboración con la Heart Failure Association (HFA) de la ESC y aprobada por la European Society of Intensive Care Medicine (ESICM) (2008) · Revista Española de Cardiología · doi:10.1016/s0300-8932(08)75740-3 · Cited by 83
STATEMENT ON SEASONAL INFLUENZA VACCINE FOR 2012-2013
(2012) · Canada Communicable Disease Report · doi:10.14745/ccdr.v38i00a02 · Cited by 51
Addario, A., Célarier, T., Bongué, B., Barth, N., Gavazzi, G., & Botelho-Nevers, É. (2023) · GeroScience · doi:10.1007/s11357-023-00807-4 · Cited by 59
“When the odds of hospitalization for IHD were analyzed by Nichol et al., the reduction was significant during the 1998–1999 season (OR: 0.80; 95% CI: 0.70–0.91) and not significant during the 1999–2000 season (OR: 0.90; 95% CI: 0.78–1.03) [36] .”
BackgroundInfluentialIncalzi, R. A., Consoli, A., Lopalco, P. L., Maggi, S., Sesti, G., Veronese, N., & Volpe, M. (2023) · Internal and Emergency Medicine · doi:10.1007/s11739-023-03456-9 · Cited by 52
Influenza in the Elderly – A Mini-Review
Pop-Vicas, A. E., & Gravenstein, S. (2010) · Gerontology · doi:10.1159/000319033 · Cited by 56
“Mixed viral and bacterial pneumonias may also occur. Influenza-related cardiovascular morbidity, with outcomes of heart disease and stroke, while less recognized, is equally important [”
BackgroundDarvishian, M., Gefenaitė, G., Turner, R., Pechlivanoglou, P., van der Hoek, W., van den Heuvel, E. R., & Hak, E. (2014) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2014.02.009 · Cited by 56
“[37] 65 years and older Nicholson et al.”
BackgroundThe Influence of Oseltamivir Treatment on the Risk of Stroke after Influenza Infection
Madjid, M., Curkendall, S. M., & Blumentals, W. A. (2008) · Cardiology · doi:10.1159/000172796 · Cited by 49
“Acute infections such as influenza have been associated with an increased risk of cardiovascular disease, including ischemic stroke. Higher rates of cardiovascular events in winter and/or coincident with the influenza season have been reported [ , , , , , , , , , , ,”
BackgroundImmunostimulant Patch Enhances Immune Responses to Influenza Virus Vaccine in Aged Mice
Guebre‐Xabier, M., Hammond, S. A., Ellingsworth, L. R., & Glenn, G. M. (2004) · Journal of Virology · doi:10.1128/jvi.78.14.7610-7618.2004 · Cited by 49
“Influenza virus vaccination is important for protection against the annual attack of influenza virus, most notably in the elderly, where high rates of influenza-related death and morbidity occur (4, 36).”
BackgroundCai, S., Feng, Z., Fennell, M. L., & Mor, V. (2011) · Health Affairs · doi:10.1377/hlthaff.2011.0029 · Cited by 53
Vardeny, O., Udell, J. A., Joseph, J., Farkouh, M. E., Hernandez, A. F., McGeer, A., Talbot, H. K., Bhatt, D. L., Cannon, C. P., Goodman, S. G., et al. (2018) · American Heart Journal · doi:10.1016/j.ahj.2018.05.007 · Cited by 48
“Moreover, influenza vaccination has been associatedwith reduced cardiac-related hospital admissions, acute exacerbations of HF, and winter mortality.(8,9) In a metaanalysis of clinical trials testing the efficacy of influenza vaccination in patients at cardiovascular risk, annual vaccination reduced the risk formajor…”
Self-citationFountoulaki, K., Tsiodras, S., Polyzogopoulou, E., Olympios, C. D., & Parissis, J. (2018) · Cardiology · doi:10.1159/000493572 · Cited by 51
Jansen, A. G. S. C., Sanders, E. A. M., Nichol, K. L., van Loon, A. M., Hoes, A. W., & Hak, E. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.08.003 · Cited by 51
“65-69 peri-season 12 ( 6-18 ) 10 (0-20) 1.14 (0.98-1.32)”
InfluentialSelf-citationWang, S., Lee, L., Chen, L.-S., & Chen, T. H.-H. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.10.011 · Cited by 48
Vaccine Preventable Diseases and Vaccination Coverage in Australia, 2001 to 2002
Brotherton, J., McIntyre, P., Puech, M., Wang, H., Gidding, H. F., Hull, B., Lawrence, G., MacIntyre, R., Wood, N., & Armstrong, D. (2004) · Communicable Diseases Intelligence · doi:10.33321/cdi.2004.28.65 · Cited by 56
Xu, B., Liu, H., Su, N., Kong, G., Bao, X., Li, J., Wang, J., Li, Y., Ma, X., Zhang, J., et al. (2013) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-13-93 · Cited by 49
“Our finding is consistent with previous studies that influenza vaccination prevented only a small fraction of hospitalizations (20%) for cardiovascular diseases [26].”
ResultLoeb, M. B., Dokainish, H., Dans, A., Palileo‐Villanueva, L. M., Roy, A., Karaye, K. M., Zhu, J., Liang, Y., Goma, F. M., Damasceno, A. A. M., et al. (2019) · American Heart Journal · doi:10.1016/j.ahj.2019.02.009 · Cited by 50
“Studies examining influenza vaccination and vascular events however have shown conflicting results.(16-27) We conducted an observational study using databases from two large clinical trials,(27) indicating that influenza From the Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, C…”
MethodWu, H.-H., Chang, Y.-Y., Kuo, S., & Chen, Y. (2019) · PLoS ONE · doi:10.1371/journal.pone.0219172 · Cited by 48
Holodinsky, J. K., Zerna, C., Malo, S., Svenson, L. W., & Hill, M. D. (2022) · The Lancet Public Health · doi:10.1016/s2468-2667(22)00222-5 · Cited by 51
Lee, C., Chang, C., Lin, C., Yeh, C., Hu, C., Wu, C., Chen, T., & Liao, C. (2020) · Journal of Clinical Periodontology · doi:10.1111/jcpe.13372 · Cited by 44
Innate Immunity and Influenza A Virus Pathogenesis: Lessons for COVID-19
Hartshorn, K. L. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.563850 · Cited by 49
“However, lower airway infection and cytokine responses may be sufficient to lead to severe illness in patients with underlying lung or cardiovascular disease through causing respiratory failure or cardiac/thrombotic events (Nichol et al., 2003).”
BackgroundAcute myocardial infarctions, strokes and influenza: seasonal and pandemic effects
FOSTER, E. D., Cavanaugh, J. E., Haynes, W. G., Yang, M. H., Gerke, A. K., Tang, F., & Polgreen, P. M. (2013) · Epidemiology and Infection · doi:10.1017/s0950268812002890 · Cited by 47
Influenza (Including Avian Influenza and Swine Influenza)
Treanor, J. J. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00167-3 · Cited by 51
Daubin, C., Parienti, J., Vincent, S., Vabret, A., du Cheyron, D., Ramakers, M., Freymuth, F., & Charbonneau, P. (2006) · Critical Care · doi:10.1186/cc5059 · Cited by 45
“A causal relationship between influenza virus infection and hospitalisation for respiratory or cardiac failure has been shown in vaccine effectiveness studies [37,38].”
BackgroundOmission of Dysphagia Therapies in Hospital Discharge Communications
Kind, A., Anderson, P., Hind, J., Robbins, J., & Smith, M. (2011) · Dysphagia · doi:10.1007/s00455-009-9266-4 · Cited by 45
“ICD-9 codes of 431, 432, 434, and 436 were used to identify stroke [37–39], and 805.”
Maniar, Y. M., Al‐Abdouh, A., & Michos, E. D. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01748-8 · Cited by 48
Jackson, M. L., Yu, O., Nelson, J. C., Naleway, A. L., Belongia, E. A., Baxter, R. P., Narwaney, K. J., Jacobsen, S. J., Shay, D. K., & Jackson, L. A. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kwt124 · Cited by 43
“The first set included covariates that have typically been used in observational influenza VE studies among seniors (4, 7, 18).”
MethodInnate immunity and myocardial adaptation to ischemia
Valeur, H. S., & Valen, G. (2008) · Basic Research in Cardiology · doi:10.1007/s00395-008-0756-6 · Cited by 48
“In a large epidemiologic study over a two-year period Nichol et al. [ 54 ] found that influenza vaccine lead to reduced hospitalization for ischemic heart disease by 19%, reduced hospitalization for cerebrovascular disease (16% the first season, 23% next season), reduced risk for pneumonia and influenza (32% and 29%,…”
BackgroundInfluenza vaccines for preventing coronary heart disease
Keller, T. T., Weeda, V. B., van Dongen, C. J. J., & Levi, M. M. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005050.pub2 · Cited by 46
Piñol‐Ripoll, G., de la Puerta, I., Santos, S. S., Purroy, F. F., & Mostacero, E. (2008) · Cerebrovascular Diseases · doi:10.1159/000151636 · Cited by 42
“In a large observational study with >140,000 elderly subjects, influenza vaccination was associated with a significant reduction in hospitalizations for cerebrovascular disease and all-cause mortality during influenza seasons [”
BackgroundAcute respiratory tract infections: A potential trigger for the acute coronary syndrome
Harskamp, R. E., & Ginkel, M. W. H. (2008) · Annals of Medicine · doi:10.1080/07853890701753672 · Cited by 48
“A recent cohort study, that included 140,000 patients with a follow-up of 2 years, assessed the effects of influenza vaccination on the risk of hospitalization for heart disease and stroke, hospitalization for pneumonia and influenza, and death from all causes, during two influenza seasons (39).”
BackgroundFrancisco, P. M. S. B., Barros, M. B. D. A., & Donalísio, M. R. (2011) · Cadernos de Saúde Pública · doi:10.1590/s0102-311x2011000300003 · Cited by 64
Santos‐Gallego, C. G., & Badimón, J. J. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.08.023 · Cited by 42
“and retrospective studies (6) and clinical trials (7) showed an association between influenza vaccination and reduced risk for MI and stroke.”
BackgroundInfluenza-Associated Neurological Complications
Tsai, J. P.-C., & BAKER, A. J. (2012) · Neurocritical Care · doi:10.1007/s12028-012-9796-8 · Cited by 45
“Influenza vaccination has also been correlated with decreased relative risks of embolic stroke [65, 84].”
Tsivgoulis, G. K., Katsanos, A. H., Zand, R., Ishfaq, M. F., Malik, M. T., Karapanayiotides, T., Voumvourakis, K. I., Tsiodras, S., & Parissis, J. (2018) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2018.01.007 · Cited by 43
Influenza Virus Infection and Risk of Acute Myocardial Infarction
Guan, X.-R., Li, X., Xin, X., Jiang, L., Cui, L.-Y., Wang, L., & Li, H. (2008) · Inflammation · doi:10.1007/s10753-008-9074-2 · Cited by 47
“Systemic cytokine release could result in lipid profile predisposing to atherosclerosis or predispose the arterial environment to a procoagulant state, resulting in acute thrombus on a pre-existent unstable or critical plaque that causes acute ischemic events [21, 27].”
BackgroundFleming, D., Verlander, N. Q., Elliot, A. J., Zhao, H., Gelb, D., JEHRING, D., & Nguyen‐Van‐Tam, J. S. (2010) · Epidemiology and Infection · doi:10.1017/s0950268810000105 · Cited by 46
Immunogenic Yeast-Based Fermentate for Cold/Flu-like Symptoms in Nonvaccinated Individuals
Moyad, M. A., Robinson, L. E., Zawada, E. T., Kittelsrud, J. M., Chen, D., Reeves, S. G., & Weaver, S. (2010) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2009.0310 · Cited by 42
“most of these controversial issues surrounding the efficacy and safety of vaccination.(12,13) Regardless, other safe and clinically tested methods that can be utilized to improve the immune status of the general public would still seem to be of interest, which would include those individuals who choose not to comply w…”
BackgroundAssociation between process quality measures for heart failure and mortality among US veterans
Wu, W., Jiang, L., Friedmann, P. D., & Trivedi, A. N. (2014) · American Heart Journal · doi:10.1016/j.ahj.2014.06.024 · Cited by 45
McElhaney, J. E. (2009) · Expert Review of Vaccines · doi:10.1586/erv.09.12 · Cited by 40
Influenza vaccination of persons with cardiovascular disease in the United States.
Singleton, J. A., WORTLEY, P. M., & Lu, P.-J. (2004) · Europe PMC (PubMed Central) · Cited by 40
Determinants of influenza vaccination among young Taiwanese children
Chen, C.-H., Chiu, P.-J., Chih, Y.-C., & Yeh, G.-L. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.01.032 · Cited by 40
High, K. P. (2007) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2007.03.007 · Cited by 43
Ward, J. R., Wilson, H. L., Francis, S. E., Crossman, D. C., & Sabroe, I. (2009) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2009.03886.x · Cited by 40
Adenovirus as a carrier for the development of influenza virus-free avian influenza vaccines
Tang, D.-C. C., Zhang, J., Toro, H., Shi, Z., & Kampen, K. R. V. (2009) · Expert Review of Vaccines · doi:10.1586/erv.09.1 · Cited by 45
Luo, C.-S., Chi, C.-C., Fang, Y.-A., Liu, J.-C., & Lee, K.-Y. (2020) · Journal of Investigative Medicine · doi:10.1136/jim-2019-001155 · Cited by 39
Kind, A., Thorpe, C. T., Sattin, J. A., Walz, S. E., & Smith, M. A. (2011) · Journal of General Internal Medicine · doi:10.1007/s11606-011-1860-0 · Cited by 43
Pediatric Influenza Prevention and Control
Principi, N., & Esposito, S. (2004) · Emerging infectious diseases · doi:10.3201/eid1004.030398 · Cited by 39
“A number of studies of adult (particularly elderly) populations have shown that knowing risk factors for influenza complications, favorable perceptions of the vaccine, and clinician recommendations are the main variables predicting the administration of influenza vaccination (1,21,22).”
BackgroundStatement on Seasonal Influenza Vaccine for 2011–2012
(2011) · Canada Communicable Disease Report · doi:10.14745/ccdr.v37i00a05 · Cited by 49
“In observational studies, immunization reduces the number of physician visits, hospitalizations and deaths in high-risk persons <65 years of age,((42)) reduces hospitalizations for cardiac disease and stroke in the elderly,((43)) and reduces hospitalization and deaths in persons with diabetes mellitus.”
BackgroundLaw, B. E., Abatzoglou, J. T., Schwalm, C. R., Byrne, D., Fann, N. L., & Nassikas, N. J. (2025) · Communications Earth & Environment · doi:10.1038/s43247-025-02314-0 · Cited by 48
“…without climate change contributing to wild fi re PM 2.5 , the mortalityreductions in the Western US would approach those seen with the in fl uenza vaccine, one of the most important public healthinterventions 29 ,thougheliminatingallglobalgreenhouseemissionsis not as simple as developing a vaccine.”
InfluentialTargeting the Skin for Microneedle Delivery of Influenza Vaccine
Koutsonanos, D. G., Compans, R. W., & Skountzou, I. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-6217-0_13 · Cited by 39
Influenza Vaccination and Cardiovascular Morbidity and Mortality
Loomba, R. S., Aggarwal, S., Shah, P. H., & Arora, R. R. (2011) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248411429965 · Cited by 38
“In contrast, Jackson et al found no significant association between influenza vaccination and risk of recurrent coronary events in patients with an initial nonfatal myocardial infarction, while Meyers et al studied patients discharged after myocardial infarction and found that influenza vaccination in the previous yea…”
BackgroundResultInfluenza and atherosclerosis: vaccination for cardiovascular disease prevention
Madjid, M., Awan, I., Ali, M., Frazier, L. Q., & Casscells, W. (2005) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.5.1.91 · Cited by 43
“Naghavi et al. (2000) Siscovick et al. (2000) Lavallee et al. (2002) Gurfinkel et al. (2002) Jackson et al. (2002) Nichol et al. (2003) Armstrong et al. (2004) Meyers et al. (2004) 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00 4.50 5.00 94 Expert Opin.”
InfluentialPolkowska, A., Begier, E. M., Bruyndonckx, R., Liang, C., Beese, C., Brestrich, G., Tran, T. M. P., Nuttens, C., Casas, M., Bayer, L. J., et al. (2024) · Infectious Diseases and Therapy · doi:10.1007/s40121-024-00951-0 · Cited by 37
“This suggests that future RSV vaccine strategies may prevent cardiovascular hospitalizations, as shown for influenza vaccines [82, 83].”
Wang, C., Wang, S., Lai, C.-T., Lin, L., Lee, C., & Chou, P. (2004) · Clinical Infectious Diseases · doi:10.1086/425323 · Cited by 41
“a recent study with a large sample size [7].”
BackgroundRodríguez, A. H., Álvarez-Rocha, L., Sirvent, J. M., Zaragoza, R., Nieto, M., Arenzana, Á., Luque, P., Socías, L., Martín, M., Navarro, D., et al. (2012) · Medicina Intensiva (English Edition) · doi:10.1016/j.medine.2012.03.002 · Cited by 40
Bartynski, W. S., Upadhyaya, A. R., & Boardman, J. F. (2009) · Journal of Computer Assisted Tomography · doi:10.1097/rct.0b013e3181993a43 · Cited by 37
Influenza vaccination in the elderly: why are the overall benefits still hotly debated?
Trucchi, C., Paganino, C., Orsi, A., De Florentis, D., & Ansaldi, F. (2015) · Journal of preventive medicine and hygiene · doi:10.15167/2421-4248/jpmh2015.56.1.474 · Cited by 44
“[34] Nichol KL, Nordin J, Mullooly J, et al.”
BackgroundHuang, C., Nguyễn, P. A., Kuo, P.-L., Iqbal, U., Hsu, Y.-H. E., & Jian, W. (2013) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2013.05.006 · Cited by 45
“influenza vaccination can reduce hospitalization of patients with heart and lungs diseases [6,8–11].”
BackgroundInfluenza vaccination and risk of stroke: Self-controlled case-series study
Asghar, Z. B., Coupland, C. A. C., & Siriwardena, A. N. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.08.013 · Cited by 36
Keenan, P. S., Elliott, M. N., Cleary, P. D., Zaslavsky, A. M., & Landon, B. E. (2009) · Medical Care · doi:10.1097/mlr.0b013e3181a39415 · Cited by 36
“Conversely, if all Medicare beneficiaries received influenza immunizations at the rates achieved in MA, which are 5 percentage points higher than in FFS, many additional deaths and hospitalizations potentially could be prevented.(31) A prior study concluded that a 3 to 4 percentage point increase in influenza immuniza…”
BackgroundLoughlin, S. M., Mortazavi, A., Garey, K. W., Rice, G. K., & Birtcher, K. K. (2007) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.5.729 · Cited by 36
“One study showed that influenza vaccination reduced hospitalizations for cardiac disease and stroke in those aged 65 years or older.(9) A casecontrol study demonstrated that influenza vaccination reduced hospitalizations for acute respiratory and cardiovascular disease in highrisk adults aged 18–64 years.”
BackgroundMulti‐Level Intervention to Prevent Influenza Infections in Older Low Income and Minority Adults
Schensul, J. J., Radda, K. E., Coman, E., & Vazquez, E. (2009) · American Journal of Community Psychology · doi:10.1007/s10464-009-9235-y · Cited by 40
“…K. Radda E. Coman E. Vazquez Institute for Community Research, 2 Hartford Square West, Ste. 100, Hartford, CT 06106, USA e-mail: Jean.Schensul@icrweb.org disabilities associated with influenza (Armstrong et al. 2001; Fedson et al. 1993; Gross et al. 1995; Nichol et al. 2003; Nordin et al. 2001).”
BackgroundAssociation of influenza vaccination with reduced risk of venous thromboembolism
Zhu, T., Carcaillon‐Bentata, L., Martinez, I., Cambou, J., Kyndt, X., Guillot, K., Vergnes, M.-C., Scarabin, P., & Emmerich, J. (2009) · Thrombosis and Haemostasis · doi:10.1160/th09-04-0222 · Cited by 36
Lin, H., Chiu, H., Ho, S., & Yang, C. (2014) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph110403639 · Cited by 39
“Three previous studies found that influenza vaccination is associated with a significant reduction in the risk of hospitalization for stroke [4,18,21].”
BackgroundFischer, T. A., Lundbye‐Christensen, S., Johnsen, S. P., Schønheyder, H. C., & Sørensen, H. T. (2004) · International Journal of Cardiology · doi:10.1016/j.ijcard.2003.10.026 · Cited by 36
Effect of influenza and pneumococcal vaccines in elderly persons in years of low influenza activity
CHRISTENSON, B., Pauksen, K., & Sylvan, S. (2008) · Virology Journal · doi:10.1186/1743-422x-5-52 · Cited by 39
“Influenza vaccination has been found to reduce the need for hospitalisation in chronic respiratory conditions and heart failure [12,15] Table 6: Deaths from all causes and the reductions of deaths according to age and vaccination status, 2003 – 2005.”
BackgroundResultInfluentialDemystifying FluMist, a new intranasal, live influenza vaccine.
Mossad, S. B. (2003) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.70.9.801 · Cited by 38
Ferdinands, J. M., & Shay, D. K. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir750 · Cited by 35
“The potential for bias in observational studies of vaccine effectiveness has long been recognized as a limitation of such studies [24, 25, 27–31], and numerous strategies to minimize bias have been proposed.”
BackgroundMadjid, M., Alfred, A., Sahai, A., Conyers, J. L., & Casscells, S. W. (2009) · PubMed · Cited by 46
Liuba, P., Aburawi, E. H., Pesonen, E. J., Andersson, S., Truedsson, L., Ylä‐Herttuala, S., & Holmberg, L. (2007) · Annals of Medicine · doi:10.1080/07853890701390111 · Cited by 35
Thorpe, J. M., Sleath, B. L., Thorpe, C. T. K., Van Houtven, C. H., Blalock, S. J., Landerman, L. R., Campbell, W. H., & Clipp, E. C. (2006) · Medical Care · doi:10.1097/01.mlr.0000215905.36968.76 · Cited by 35
An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)
Meningococcal, C. (2007) · Cited by 35
Influenza and Emergency Department Utilization by Elders
Schull, M. J., Mamdani, M., & Fang, J. (2005) · Academic Emergency Medicine · doi:10.1111/j.1553-2712.2005.tb01953.x · Cited by 35
Statement on Seasonal Influenza Vaccine for 2013–2014
(2013) · Canada Communicable Disease Report · doi:10.14745/ccdr.v39i00a04 · Cited by 36
Dip, R. M., & Cabrera, M. A. S. (2010) · Cadernos de Saúde Pública · doi:10.1590/s0102-311x2010000500025 · Cited by 34
Rümke, H. C., Richardus, J. H., Rombo, L., Pauksens, K., Plaßmann, G., Durand, C., Devaster, J., Dewé, W., & Oostvogels, L. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-348 · Cited by 34
“Impairment of T cell responses due to aging is therefore considered to be an important factor that limits the responses to vaccination, and it has been proposed that correlates of vaccine-mediated protection against influenza in older adults should include measures of cell-mediated responses [5,33].”
BackgroundNew Horizons of National Immunization Calendar
Namazova-Baranova, L. S., Fedoseenko, М. V., & Aa, B. (2019) · Вопросы современной педиатрии · doi:10.15690/vsp.v18i1.1988 · Cited by 34
“В Швеции одновременное применение полисахаридной пневмококковой и инактивированной противогриппозной вакцины значительно сократило риск смерти пожилых людей в стационаре от пневмонии и сердечной недостаточности [45].”
Liprandi, Á. S., Liprandi, M. I. S., Zaidel, E. J., Aisenberg, G. M., Baranchuk, A. M., Barbosa, E. C. D., Sánchez, G. B., Alexander, B., Lanas, F. T., López-Santi, R., et al. (2021) · Global Heart · doi:10.5334/gh.1069 · Cited by 40
Salway, T. J., Skowronski, D. M., Hiebert, B. M., Janjua, N. Z., Roos, L. L., Caeseele, P. G. V., LAW, B. J., & Serres, G. D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022618 · Cited by 35
“In most studies, adjustment for underlying health conditions further increased estimates of IVE [10,19, 21,23,25,28]—an effect believed to be the result of accounting for confounding by indication whereby higher-risk patients may be more likely to receive vaccine [32].”
BackgroundHorby, P., Williams, A., Burgess, M. A., & Wang, H. (2005) · Australian and New Zealand Journal of Public Health · doi:10.1111/j.1467-842x.2005.tb00745.x · Cited by 38
Spoto, S., Valeriani, E., Locorriere, L., Anguissola, G. B., Pantano, A. L., Terracciani, F., Riva, E., Ciccozzi, M., Costantino, S., & Angeletti, S. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-018-3606-7 · Cited by 39
Update on medicines for smoking cessation
McDonough, M. (2015) · Australian Prescriber · doi:10.18773/austprescr.2015.038 · Cited by 44
Determinants of influenza and pneumococcal vaccination in patients with chronic lung diseases
Schoefer, Y., Schaberg, T., Raspe, H. H., & Schaefer, T. (2007) · Journal of Infection · doi:10.1016/j.jinf.2007.06.002 · Cited by 33
Effectiveness of the influenza vaccination program for the elderly in Taiwan
Chiu, P.-J., Chen, C.-H., & Chih, Y.-C. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.11.055 · Cited by 32
Excess Deaths Attributable to Influenza-Like Illness in the ESRD Population
Gilbertson, D. T., Rothman, K. J., Chertow, G. M., Bradbury, B. D., Brookhart, M. A., Liu, J., Winkelmayer, W. C., Stürmer, T., Monda, K. L., Herzog, C. A., et al. (2019) · Journal of the American Society of Nephrology · doi:10.1681/asn.2018060581 · Cited by 33
A cost-effectiveness analysis of South Africa’s seasonal influenza vaccination programme
Edoka, I., Kohli-Lynch, C. N., Fraser, H., Hofman, K., Tempia, S., McMorrow, M., Ramkrishna, W., Lambach, P., Hutubessy, R. C. W., & Cohen, C. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.11.028 · Cited by 32
Atherosclerosis by Virus Infection—A Short Review
Jung, S.-H., & Lee, K. (2022) · Biomedicines · doi:10.3390/biomedicines10102634 · Cited by 33
“Infections by specific strains of influenza viruses can be prevented by vaccination and treated by antiviral drugs, such as oseltamivir phosphate (Tamiflu®), and it has been reported that successful influenza vaccination can prevent the development of cardiac diseases associated with influenza viruses [22,23].”
BackgroundDouble Dose vs. Standard Dose Influenza Vaccination in Patients with Heart Failure: A Pilot Study
Ermen, A. V., Hermanson, M. P., Moran, J. M., Sweitzer, N. K., Johnson, M. R., & Vardeny, O. (2013) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs207 · Cited by 35
“Annual vaccination has been associated with reduced cardiovascular and all-cause hospitalizations and mortality.(5,6) We and others have shown that the presence and severity of heart failure were associated with reduced humoral and altered cell-mediated responses to influenza vaccine, which may potentially reduce the…”
BackgroundA virologic survey of patients admitted to a critical care unit for acute cardiorespiratory failure
Carrat, F., Leruez‐Ville, M., Tonnellier, M., Baudel, J.-L., Deshayes, J., Meyer, P., Maury, É., Galimand, J., Rouzioux, C., & Offenstadt, G. (2005) · Intensive Care Medicine · doi:10.1007/s00134-005-2861-4 · Cited by 32
“However, a causal relationship between influenza virus infection and hospitalization for respiratory or cardiac disease has been detected in vaccine effectiveness studies [16, 17] , which showed that influenza immunization reduced hospitalizations.”
Host Single‐Nucleotide Polymorphisms and Altered Responses to Inactivated Influenza Vaccine
Tang, Y., Li, H., Wu, H., Shyr, Y., & Edwards, K. M. (2007) · The Journal of Infectious Diseases · doi:10.1086/521370 · Cited by 32
“Vaccination against influenza has substantial health-related and economic benefits for both children and adults [1].”
BackgroundMedical management of chronic stable angina
Wee, Y. S., Burns, K., & Bett, N. (2015) · Australian Prescriber · doi:10.18773/austprescr.2015.042 · Cited by 38
Improving immunogenicity and effectiveness of influenza vaccine in older adults
Cao, W., Kim, J. H., Chirkova, T., Reber, A. J., Biber, R., Shay, D. K., & Sambhara, S. R. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.137 · Cited by 34
The seasonality of acute coronary syndrome and its relations with climatic parameters
Li, Y., Du, T., Lewin, M. R., Wang, H., Ji, X., Zhang, Y., Xu, T., Xu, L., & Wu, J. S. (2010) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2010.02.027 · Cited by 31
“Previous study [35] has shown that influenza vaccination can lower the rates of pulmonary infection and acute cardiac events further supporting the patterns observed by Biyik and his colleagues.”
ResultInfluenza-Associated Hospitalizations for Cardiovascular Diseases in the Tropics
Ang, L. W., Yap, J. J. L., Lee, V., Chng, W. Q., Jaufeerally, F. R., Lam, C. S. P., Cutter, J. L., Yeo, K. K., & Ma, S. (2017) · American Journal of Epidemiology · doi:10.1093/aje/kwx001 · Cited by 31
“In the elderly, influenza vaccination has been shown to reduce hospitalizations for cardiac disease (27) as well as cardiovascular deaths (28).”
Background
Metadata
- Authors
- Nichol, K. L., Nordin, J., Mullooly, J., Lask, R., Fillbrandt, K., & Iwane, M.
- Affiliations
- University of Minnesota (US)
- HealthPartners (US)
- Kaiser Permanente (US)
- Centers for Disease Control and Prevention (US)
- ORCID
- Nordin, James
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-04-03
- Volume
- 348
- Issue
- 14
- Pages
- 1322-1332
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2116971894
- Cited by
- 752
- References
- 42
- Citations by year
- 2026: 12 · 2025: 20 · 2024: 10 · 2023: 15 · 2022: 14 · 2021: 17 · 2020: 23 · 2019: 26 · 2018: 29 · 2017: 25 · 2016: 19 · 2015: 33 · 2014: 29 · 2013: 42 · 2012: 50
- FWCI
- 45.37
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
- Keywords
- influenza vaccination, influenza, stroke, heart disease, hospitalization, older adults, pneumonia, mortality, ischemic heart disease, cerebrovascular disease, upper respiratory tract infection, managed care, community-dwelling older adults, vaccine effectiveness, dementia, comorbidities, subgroup analysis
- MeSH terms
- Aged, Aged, 80 and over, Female, Heart Diseases, Hospitalization, Humans, Influenza, Human, Influenza Vaccines, Male, Mortality, Pneumonia, Risk, Logistic Models, Odds Ratio, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.